CJC-1295 DAC

Description

CJC-1295 DAC is a modified synthetic analog of Growth Hormone Releasing Hormone (GHRH) engineered to support extended growth hormone signaling research. The Drug Affinity Complex (DAC) modification allows the peptide to bind reversibly to serum albumin, significantly increasing its half-life compared to non-DAC versions.

In controlled human physiology studies, CJC-1295 DAC has been observed to stimulate the natural pulsatile release of growth hormone (GH), leading to sustained elevations in circulating IGF-1 levels. Growth hormone and IGF-1 pathways are involved in multiple biological processes including protein synthesis signaling, lean tissue pathways, lipid metabolism regulation, and endocrine system modulation.

Due to its prolonged activity profile, CJC-1295 DAC is frequently examined in research models evaluating sustained GH stimulation and metabolic signaling responses over extended periods.

Each vial contains 5mg of lyophilized CJC-1295 DAC, manufactured and HPLC tested to ensure ≥99% purity and batch consistency. The sterile lyophilized format ensures stability prior to controlled reconstitution.

Product Specifications:

• Peptide Name: CJC-1295 DAC

• Quantity: 5mg per vial

• Purity: ≥99% (HPLC tested)

• Form: Lyophilized powder in sterile vial

• Modification: Drug Affinity Complex (DAC)

• Appearance: White to off-white lyophilized cake

• Grade: Research Use Only

• Storage: Refrigerate after reconstitution

• Certificate of Analysis: Available upon request

⚠ This product is sold strictly for laboratory research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.